KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $27.9 million.

  • West Pharmaceutical Services' Long-Term Deferred Tax fell 2579.79% to $27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.9 million, marking a year-over-year decrease of 2579.79%. This contributed to the annual value of $26.0 million for FY2024, which is 116.73% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Long-Term Deferred Tax of $27.9 million as of Q3 2025, which was down 2579.79% from $29.7 million recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Long-Term Deferred Tax ranged from a high of $99.0 million in Q1 2023 and a low of $17.3 million during Q3 2023
  • In the last 5 years, West Pharmaceutical Services' Long-Term Deferred Tax had a median value of $33.9 million in 2024 and averaged $44.2 million.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first skyrocketed by 25874.44% in 2021, then crashed by 7878.79% in 2024.
  • West Pharmaceutical Services' Long-Term Deferred Tax (Quarter) stood at $48.5 million in 2021, then surged by 35.26% to $65.6 million in 2022, then tumbled by 60.82% to $25.7 million in 2023, then grew by 1.17% to $26.0 million in 2024, then increased by 7.31% to $27.9 million in 2025.
  • Its Long-Term Deferred Tax was $27.9 million in Q3 2025, compared to $29.7 million in Q2 2025 and $26.0 million in Q1 2025.